← FDA DRUG APPROVALS

FDA ANDA · ANDA040774

HYDROCHLOROTHIAZIDE

Sponsor: APOTEX

APPLICATION
ANDA040774
TYPE
ANDA
ORIGINAL APPROVAL
2007-10-03
LATEST ACTION
2008-04-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 25MG · TABLET · ORAL
HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 50MG · TABLET · ORAL

Approval history

2008-04-04Manufacturing (CMC) · Supplement 1AP
2008-04-04Manufacturing (CMC) · Supplement 2AP
2007-10-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →